glp-1 obesity drug news weight loss drugs to become cheaper for some under temporary Medicare program World Health Organization recommends GLP-1

EASL Congress 2023, June 21-24, Vienna

Back Mller, MU, Preker, A (4 Jan 2024) 'Interview with weight loss drugs inventor Lotte Bjerre Knudsen', Spiegel International

Cancers 16 , 2377 (2024)

Quantitative data between groups were compared by one-way ANOVA if normally distributed or KruskalWallis H-test if not

Patients should work with their prescriber to titrate the medication dose appropriately and avoid excessively restrictive eating patterns

Regarding glucose-metabolism, two studies found that GLP-1(9-36), GLP-1 (7-36) and Liraglutide significantly inhibited insulin-stimulated glucose uptake [12, 13], with Liraglutide showing a dose dependent inhibition, with a maximum at a concentration of 1000 nM [12, 13]